Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze SRPT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SRPT investment potential.

What is SRPT stock price today?

Get real-time SRPT stock price, historical data, and price charts on Financhill. Track SRPT performance with our advanced analysis tools.

Is SRPT a good investment?

Evaluate SRPT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SRPT stock?

To buy SRPT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SRPT?

View detailed market capitalization data and company valuation metrics for SRPT on our comprehensive analysis page.

What is the P/E ratio of SRPT?

Use our fundamental analysis tools to view SRPT P/E ratio and compare valuation metrics with industry peers.

What are SRPT earnings?

View SRPT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Sarepta Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

SRPT
Sarepta Therapeutics, Inc.

Last Price:

$22.84

Seasonality Move:

10.18%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Sarepta Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Sarepta Therapeutics, Inc. has on average historically risen by 30.9% based on the past 28 years of stock performance.
Sarepta Therapeutics, Inc. has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%
Is Sarepta Therapeutics, Inc. Stock Undervalued?

The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.84. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Sarepta Therapeutics, Inc. has on average historically risen by 30.9% based on the past 28 years of stock performance.

Sarepta Therapeutics, Inc. Stock Rating

Sell

Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. overpriced?

Sarepta Therapeutics, Inc. has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%

Sarepta Therapeutics, Inc. Stock Price History

Is SRPT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

sarepta.com

52-Week Data

52-Week High:

131.31

52-Week Low:

10.42

Prediction Charts

Market Cap:

2.3B

Price in USD:

21.84

Volume:

3.5M

Beta:

1.01

Technical Analysis

SMA50:

20.56

SMA100:

19.10

SMA200:

37.10

52-Wk Change:

-82.67%

Stock Predictions

Is Sarepta Therapeutics, Inc. stock public?

Yes, Sarepta Therapeutics, Inc. is a publicly traded company.
What is the Sarepta Therapeutics, Inc. stock quote today?

The Sarepta Therapeutics, Inc. stock price is 21.84 USD today.
How to buy Sarepta Therapeutics, Inc. stock online?

You can buy Sarepta Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	17.51	18.81	20.15	17.51
Nov-17	18.61	17.54	18.70	17.38
Nov-18	17.38	17.44	17.73	16.94
Nov-19	17.41	16.39	17.43	15.94
Nov-20	16.69	16.48	17.60	16.31
Nov-21	16.40	17.69	17.72	16.33
Nov-24	17.76	18.91	19.14	17.62
Nov-25	18.91	19.35	19.45	18.73
Nov-26	19.40	20.95	21.21	19.35
Nov-28	21.11	21.34	21.38	20.72
Dec-1	20.85	19.72	21.00	19.67
Dec-2	19.82	20.47	20.53	19.37
Dec-3	19.75	21.84	21.93	19.43
Dec-4	21.55	22.82	23.00	21.47

Sarepta Therapeutics, Inc. Earnings

Sarepta Therapeutics, Inc. Earnings Report: Per Share Sarepta Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics, Inc. Forecast Revenue Growth

Sarepta Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $5.31 per share.

* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.